| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 7.54T | 7.16T | 7.14T | 6.40T | 5.52T |
| Gross Profit | 1.17T | 1.10T | 1.09T | 911.14B | 801.49B |
| EBITDA | 949.08B | 870.48B | 756.05B | 790.43B | 701.51B |
| Net Income | 443.75B | 419.08B | 312.79B | 314.63B | 263.90B |
Balance Sheet | |||||
| Total Assets | 8.73T | 8.13T | 9.09T | 7.41T | 7.43T |
| Cash, Cash Equivalents and Short-Term Investments | 1.19T | 986.53B | 789.39B | 733.85B | 867.81B |
| Total Debt | 811.28B | 738.58B | 898.34B | 943.64B | 1.05T |
| Total Liabilities | 3.02T | 2.94T | 3.35T | 2.83T | 2.94T |
| Stockholders Equity | 5.49T | 4.98T | 5.53T | 4.38T | 4.30T |
Cash Flow | |||||
| Free Cash Flow | 140.85B | 378.67B | 515.42B | 188.41B | 23.49B |
| Operating Cash Flow | 511.02B | 758.74B | 961.83B | 602.72B | 395.64B |
| Investing Cash Flow | -16.89B | 121.90B | -459.49B | -363.68B | -301.58B |
| Financing Cash Flow | -355.00B | -677.43B | -496.66B | -400.10B | -159.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥717.62B | 14.05 | 7.20% | 2.41% | 2.31% | 26.37% | |
73 Outperform | ¥1.67T | 12.67 | 13.69% | 2.65% | 11.98% | 22.34% | |
72 Outperform | ¥7.95T | 15.56 | 8.97% | 1.38% | 6.56% | 38.17% | |
68 Neutral | ¥5.18T | 11.95 | 6.98% | 2.98% | 5.28% | 12.66% | |
66 Neutral | ¥608.97B | 43.48 | 3.35% | 3.18% | 2.15% | -6.81% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥1.87T | 9.32 | 8.34% | 2.03% | 4.53% | 65.12% |